201 related articles for article (PubMed ID: 24703838)
1. Antagonism of tumoral prolactin receptor promotes autophagy-related cell death.
Wen Y; Zand B; Ozpolat B; Szczepanski MJ; Lu C; Yuca E; Carroll AR; Alpay N; Bartholomeusz C; Tekedereli I; Kang Y; Rupaimoole R; Pecot CV; Dalton HJ; Hernandez A; Lokshin A; Lutgendorf SK; Liu J; Hittelman WN; Chen WY; Lopez-Berestein G; Szajnik M; Ueno NT; Coleman RL; Sood AK
Cell Rep; 2014 Apr; 7(2):488-500. PubMed ID: 24703838
[TBL] [Abstract][Full Text] [Related]
2. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
3. Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies.
Standing D; Dandawate P; Anant S
Front Endocrinol (Lausanne); 2022; 13():1112987. PubMed ID: 36714582
[TBL] [Abstract][Full Text] [Related]
4. Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
Tan D; Chen KE; Khoo T; Walker AM
Cancer Lett; 2011 Nov; 310(1):101-8. PubMed ID: 21775057
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer.
Wen Y; Wang Y; Chelariu-Raicu A; Stur E; Liu Y; Corvigno S; Bartsch F; Redfern L; Zand B; Kang Y; Liu J; Baggerly K; Sood AK
Mol Cancer Ther; 2020 Sep; 19(9):1943-1954. PubMed ID: 32737156
[TBL] [Abstract][Full Text] [Related]
6. Connections between prolactin and ovarian cancer.
Alkharusi A; AlMuslahi A; AlBalushi N; AlAjmi R; AlRawahi S; AlFarqani A; Norstedt G; Zadjali F
PLoS One; 2021; 16(8):e0255701. PubMed ID: 34358244
[TBL] [Abstract][Full Text] [Related]
7. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
Scotti ML; Langenheim JF; Tomblyn S; Springs AE; Chen WY
Breast Cancer Res Treat; 2008 Sep; 111(2):241-50. PubMed ID: 17955362
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic Prolactin Regulation of Luteinizing Hormone Secretion in the Female Rat.
Grachev P; Li XF; Goffin V; O'Byrne KT
Endocrinology; 2015 Aug; 156(8):2880-92. PubMed ID: 25993525
[TBL] [Abstract][Full Text] [Related]
10. High Prolactin Concentration Induces Ovarian Granulosa Cell Oxidative Stress, Leading to Apoptosis Mediated by
Yang R; Duan C; Zhang S; Guo Y; Shan X; Chen M; Yue S; Zhang Y; Liu Y
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833858
[TBL] [Abstract][Full Text] [Related]
11. Prolactin and its receptor as therapeutic targets in glioblastoma multiforme.
Asad AS; Nicola Candia AJ; Gonzalez N; Zuccato CF; Abt A; Orrillo SJ; Lastra Y; De Simone E; Boutillon F; Goffin V; Seilicovich A; Pisera DA; Ferraris MJ; Candolfi M
Sci Rep; 2019 Dec; 9(1):19578. PubMed ID: 31862900
[TBL] [Abstract][Full Text] [Related]
12. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
Beck MT; Chen NY; Franek KJ; Chen WY
Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
[TBL] [Abstract][Full Text] [Related]
13. The role of prolactin receptor in GH signaling in breast cancer cells.
Xu J; Sun D; Jiang J; Deng L; Zhang Y; Yu H; Bahl D; Langenheim JF; Chen WY; Fuchs SY; Frank SJ
Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981
[TBL] [Abstract][Full Text] [Related]
14. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
Langenheim JF; Tan D; Walker AM; Chen WY
Mol Endocrinol; 2006 Mar; 20(3):661-74. PubMed ID: 16269515
[TBL] [Abstract][Full Text] [Related]
15. Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy.
López-Ozuna VM; Hachim IY; Hachim MY; Lebrun JJ; Ali S
Sci Rep; 2016 Aug; 6():30934. PubMed ID: 27480353
[TBL] [Abstract][Full Text] [Related]
16. A Novel Mechanism of hPRL-G129R, a Prolactin Antagonist, Inhibits Human Breast Cancer Cell Proliferation and Migration.
Li R; Yang Y; Lan H; Wang Y; Ge Z; Liu X; Zhou Y; Zhang W; Xian L; Yuan H
Endocrinology; 2023 Nov; 164(12):. PubMed ID: 37934803
[TBL] [Abstract][Full Text] [Related]
17. Expression of prolactin and its receptor in human breast carcinoma.
Reynolds C; Montone KT; Powell CM; Tomaszewski JE; Clevenger CV
Endocrinology; 1997 Dec; 138(12):5555-60. PubMed ID: 9389544
[TBL] [Abstract][Full Text] [Related]
18. Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.
Hachim IY; Hachim MY; Lopez VM; Lebrun JJ; Ali S
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):238-45. PubMed ID: 26317306
[TBL] [Abstract][Full Text] [Related]
19. Implication of alpha4 phosphoprotein and the rapamycin-sensitive mammalian target-of-rapamycin pathway in prolactin receptor signalling.
Boudreau RT; Sangster SM; Johnson LM; Dauphinee S; Li AW; Too CK
J Endocrinol; 2002 Jun; 173(3):493-506. PubMed ID: 12065239
[TBL] [Abstract][Full Text] [Related]
20. Expression of autocrine prolactin and the short isoform of prolactin receptor are associated with inflammatory response and apoptosis in monocytes stimulated with Mycobacterium bovis proteins.
López-Rincón G; Mancilla R; Pereira-Suárez AL; Martínez-Neri PA; Ochoa-Zarzosa A; Muñoz-Valle JF; Estrada-Chávez C
Exp Mol Pathol; 2015 Jun; 98(3):517-26. PubMed ID: 25797370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
